Diluted
loss per share excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2022 and 2021, the following
potential common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
Schedule
of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Common stock warrants |
|
|
511,333,351,090 |
|
|
|
54,280,658 |
|
Convertible preferred stock |
|
|
452,995,411,111 |
|
|
|
48,188,965 |
|
Convertible debentures |
|
|
28,777,833,333 |
|
|
|
2,877,783 |
|
Stock options |
|
|
26 |
|
|
|
26 |
|
Anti-dilutive
shares |
|
|
993,106,595,560 |
|
|
|
105,347,432 |
|
|